Aripiprazole injectable suspension formulation having prolonged shelf life
US11786522B2 · kind B2 · utility
0Cited by
22References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2016 |
| Grant date | Oct 17, 2023 |
| Priority date | — |
| Expiry date | Sep 23, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention belongs to the field of pharmaceutical formulation, and particularly relates to an aripiprazole injectable suspension formulation having prolonged shelf life, and methods of using the formulation in treating schizophrenia and related diseases. In another aspect, the present invention also relates to a method of prolonging shelf life of an aripiprazole injectable suspension formulation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.